Cargando…

Matrix Metalloproteinases Contribute to Neuronal Dysfunction in Animal Models of Drug Dependence, Alzheimer's Disease, and Epilepsy

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) remodel the pericellular environment by regulating the cleavage of extracellular matrix proteins, cell surface components, neurotransmitter receptors, and growth factors that mediate cell adhesion, synaptogenesis, s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizoguchi, Hiroyuki, Yamada, Kiyofumi, Nabeshima, Toshitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253438/ https://www.ncbi.nlm.nih.gov/pubmed/22235372 http://dx.doi.org/10.1155/2011/681385

Ejemplares similares

Roles of Matrix Metalloproteinases and Their Targets in Epileptogenesis and Seizures
por: Mizoguchi, Hiroyuki, et al.
Publicado: (2013)

Alzheimer’s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment
por: Nakai, Tsuyoshi, et al.
Publicado: (2021)

Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives
por: Yamada, Kiyofumi, et al.
Publicado: (2015)

Dysfunction of Serotonergic and Dopaminergic Neuronal Systems in the Antidepressant-Resistant Impairment of Social Behaviors Induced by Social Defeat Stress Exposure as Juveniles
por: Hasegawa, Sho, et al.
Publicado: (2018)

Mice carrying a schizophrenia-associated mutation of the Arhgap10 gene are vulnerable to the effects of methamphetamine treatment on cognitive function: association with morphological abnormalities in striatal neurons
por: Hada, Kazuhiro, et al.
Publicado: (2021)

New Strategies for the Treatment of Neuropsychiatric Disorders Based on Reelin Dysfunction
por: Tsuneura, Yumi, et al.
Publicado: (2022)

Elevated matrix metalloproteinase‐9 levels in neuronal extracellular vesicles in Alzheimer’s disease
por: Gu, Dongmei, et al.
Publicado: (2020)

Cell type-specific activation of mitogen-activated protein kinase in D1 receptor-expressing neurons of the nucleus accumbens potentiates stimulus-reward learning in mice
por: Bin Saifullah, Md. Ali, et al.
Publicado: (2018)

Pharmacologic Treatment with GABA(B) Receptor Agonist of Methamphetamine-Induced Cognitive Impairment in Mice
por: Mizoguchi, Hiroyuki, et al.
Publicado: (2011)

Matrix Metalloproteinases and Their Multiple Roles in Alzheimer's Disease
por: Wang, Xiang-Xiang, et al.
Publicado: (2014)

Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development
por: Bronisz, Elżbieta, et al.
Publicado: (2016)

Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation
por: González-Zamora, Jorge, et al.
Publicado: (2022)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease
por: Aksnes, Mari, et al.
Publicado: (2023)

A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities
por: ZHANG, HONGQI, et al.
Publicado: (2014)

Matrix metalloproteinase-1 contribution to sarcoma cell invasion
por: Garamszegi, Nandor, et al.
Publicado: (2012)

Matrix Metalloproteinases Contribute to the Calcification Phenotype in Pseudoxanthoma Elasticum
por: Plümers, Ricarda, et al.
Publicado: (2023)

Matrix metalloproteinase 7 contributes to intestinal barrier dysfunction by degrading tight junction protein Claudin-7
por: Xiao, Ying, et al.
Publicado: (2022)

Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers
por: Kamei, Hiroyuki, et al.
Publicado: (2011)

Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations☆
por: Di, Fei, et al.
Publicado: (2012)

Overexpression of astroglial major histocompatibility complex class I in the medial prefrontal cortex impairs visual discrimination learning in mice
por: Wulaer, Bolati, et al.
Publicado: (2020)

Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3
por: Yamada, Shinnosuke, et al.
Publicado: (2018)

Comparison of the Effects of a Brand-name Drug and Its Generic Drug on the Quality of Life of Alzheimer’s Disease Patients
por: Sakakibara, Mikio, et al.
Publicado: (2015)

Contributions of Matrix Metalloproteinases to Neural Plasticity, Habituation, Associative Learning and Drug Addiction
por: Wright, John W., et al.
Publicado: (2009)

Elevated Plasma Levels of Matrix Metalloproteinase-3 and Tissue-Inhibitor of Matrix Metalloproteinases-1 Associate With Organ Dysfunction and Mortality in Sepsis
por: Jones, Tiffanie K., et al.
Publicado: (2022)

Matrix Metalloproteinase-2 in the Development of Diabetic Retinopathy and Mitochondrial Dysfunction
por: Mohammad, Ghulam, et al.
Publicado: (2010)

Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases
por: Freise, Christian, et al.
Publicado: (2016)

Post-Translational Modification-Dependent Activity of Matrix Metalloproteinases
por: Madzharova, Elizabeta, et al.
Publicado: (2019)

Matrix metalloproteinase 13, a new target for therapy in Alzheimer's disease
por: Paumier, Jean-Michel, et al.
Publicado: (2019)

PT563. Prenatal nicotine exposure impairs the proliferation of neuronal progenitors, leading to fewer glutamatergic neurons in the medial prefrontal cortex
por: Mamiya, Takayoshi, et al.
Publicado: (2016)

Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases
por: Yamada, Hiroshi, et al.
Publicado: (2016)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Ablation of Matrix Metalloproteinase-9 Prevents Cardiomyocytes Contractile Dysfunction in Diabetics
por: Prathipati, Priyanka, et al.
Publicado: (2016)

Epilysin (matrix metalloproteinase-28) contributes to airway epithelial cell survival
por: Manicone, Anne M, et al.
Publicado: (2011)

Kupffer-derived matrix metalloproteinase-9 contributes to liver fibrosis resolution
por: Feng, Min, et al.
Publicado: (2018)

Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan
por: Yang, Mei-Due, et al.
Publicado: (2017)

DP-b99 Modulates Matrix Metalloproteinase Activity and Neuronal Plasticity
por: Yeghiazaryan, Marine, et al.
Publicado: (2014)

Genetic and animal model analyses reveal the pathogenic role of a novel deletion of RELN in schizophrenia
por: Sobue, Akira, et al.
Publicado: (2018)

Matrix metalloproteinase 9-dependent Notch signaling contributes to kidney fibrosis through peritubular endothelial–mesenchymal transition
por: Zhao, Ye, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hd2vgbdg2br4hli49h0gf5lt80